Current State of GLP-1RA Use in Pediatric Medicine Because of the widespread success of GLP-1RAs in adults and in light of treatment challenges, there has been significant motivation to learn more about how they may benefit the pediatric population
In addition to a reduction in body mass index, there were also improvements in insulin sensitivity, visceral fat mass, fat-regulating hormones, waist circumference, and markers of inflammation in these studies
While individual GLP-1 receptor agonists may vary in their specific applications (some are approved primarily for diabetes, others for chronic weight management), their core mechanism of action offers a powerful approach to supporting weight loss efforts
Switching from earlier in the week to later This direction is easier
Subcutaneous delivery supports controlled systemic exposure and predictable GH pulse activation in research protocols
However, long-acting GLP-1s, like victoza, trulicity and ozempic, are sometimes prescribed off-label in clinical practice for individuals with T1D